The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Fickenscher James E since 2005.
This trader's CIK number is 1327442.
At the time of last reporting, Fickenscher James E was the Chief Financial Officer of Zynerba Pharmaceuticals, Inc.. (stock ticker symbol ZYNE).
Also see all insider trading activities at Zynerba Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2013 | AUXL | 0 | $0 | 71,067 | $1,447,421 | 71,067 | $339,700 |
| 2011 | AUXL | 1,610 | $25,024 | 0 | $0 | 0 | $0 |
| 2009 | AUXL | 0 | $0 | 36,325 | $1,042,061 | 28,933 | $138,299 |
| 2008 | AUXL | 0 | $0 | 11,675 | $307,122 | 0 | $0 |
| 2007 | AUXL | 1,510 | $20,196 | 0 | $0 | 0 | $0 |
| 2006 | AUXL | 1,000 | $6,430 | 0 | $0 | 0 | $0 |
| 2005 | AUXL | 5,000 | $21,090 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | ATRS | 135,000 | $97,200 | 0 | $0 | 0 | $0 |
| 2014 | ATRS | 40,000 | $99,800 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | ZYNE | 0 | $0 | 26,767 | $22,556 | 0 | $0 |
| 2022 | ZYNE | 0 | $0 | 6,013 | $6,614 | 0 | $0 |
| 2018 | ZYNE | 8,518 | $50,843 | 0 | $0 | 0 | $0 |
| 2017 | ZYNE | 5,200 | $103,064 | 0 | $0 | 0 | $0 |
| 2016 | ZYNE | 7,000 | $98,570 | 0 | $0 | 0 | $0 |
1. Auxilium Pharmaceuticals Inc (AUXL)
2. Antares Pharma, Inc. (ATRS)
3. Zynerba Pharmaceuticals, Inc. (ZYNE)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2013-12-11 | AUXL | Option Ex | 71,067 | 4.78 | 339,700 |
| 2013-12-11 | AUXL | Sale | 71,067 | 20.37 | 1,447,421 |
| 2011-11-03 | AUXL | Buy | 1,610 | 15.54 | 25,024 |
| 2009-09-14 | AUXL | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-09-14 | AUXL | Sale | 4,000 | 30.70 | 122,812 |
| 2009-09-08 | AUXL | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-09-08 | AUXL | Sale | 4,000 | 30.00 | 120,008 |
| 2009-07-15 | AUXL | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-07-15 | AUXL | Sale | 4,000 | 30.01 | 120,024 |
| 2009-06-15 | AUXL | Sale | 4,000 | 27.21 | 108,840 |
| 2009-06-15 | AUXL | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-05-22 | AUXL | Option Ex | 4,000 | 4.78 | 19,120 |
| 2009-05-22 | AUXL | Sale | 4,000 | 25.02 | 100,092 |
| 2009-04-17 | AUXL | Sale | 500 | 25.00 | 12,500 |
| 2009-04-16 | AUXL | Sale | 3,500 | 25.01 | 87,531 |
| 2009-04-17 | AUXL | Option Ex | 500 | 4.78 | 2,390 |
| 2009-04-16 | AUXL | Option Ex | 3,500 | 4.78 | 16,730 |
| 2009-03-16 | AUXL | Option Ex | 4,933 | 4.78 | 23,579 |
| 2009-03-16 | AUXL | Sale | 4,933 | 29.79 | 146,954 |
| 2009-02-17 | AUXL | Sale | 3,450 | 31.55 | 108,837 |
| 2009-01-14 | AUXL | Sale | 3,942 | 29.04 | 114,463 |
| 2008-12-19 | AUXL | Sale | 11,675 | 26.31 | 307,122 |
| 2007-05-08 | AUXL | Buy | 1,510 | 13.38 | 20,196 |
| 2006-03-10 | AUXL | Buy | 1,000 | 6.43 | 6,430 |
| 2005-11-11 | AUXL | Buy | 5,000 | 4.22 | 21,090 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-03-18 | ATRS | Buy | 135,000 | .72 | 97,200 |
| 2014-12-11 | ATRS | Buy | 40,000 | 2.50 | 99,800 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-09-13 | ZYNE | Sale | 8,998 | 1.33 | 11,931 |
| 2023-01-23 | ZYNE | Sale | 17,769 | .60 | 10,625 |
| 2022-07-19 | ZYNE | Sale | 6,013 | 1.10 | 6,614 |
| 2018-08-06 | ZYNE | Buy | 8,518 | 5.97 | 50,843 |
| 2017-05-12 | ZYNE | Buy | 5,200 | 19.82 | 103,064 |
| 2016-12-06 | ZYNE | Buy | 3,000 | 14.15 | 42,450 |
| 2016-12-07 | ZYNE | Buy | 4,000 | 14.03 | 56,120 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fickenscher James E (Chief Financial Officer of Zynerba Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.